Tong Guo-Jun, Zhang Gui-Yang, Liu Jian, Zheng Zhao-Zheng, Chen Yan, Niu Ping-Ping, Xu Xu-Ting
General Surgery Department, Huzhou Central Hospital, Huzhou 313000, Zhejiang Province, China.
Central Laboratory, Huzhou Central Hospital, Huzhou 313000, Zhejiang Province, China.
World J Clin Oncol. 2018 Nov 10;9(7):148-161. doi: 10.5306/wjco.v9.i7.148.
To analyze the survival trends in colorectal cancer (CRC) based on the different classifications recommended by the seventh and eighth editions of the American Joint Committee on Cancer staging system (AJCC-7 and AJCC-8).
The database from our institution was queried to identify patients with pathologically confirmed stage 0-IV CRC diagnosed between 2006 and 2012. Data from 2080 cases were collected and 1090 cases were evaluated through standardized inclusion and exclusion criteria. CRC was staged by AJCC-7 and then restaged by AJCC-8. Five-year disease-free survival (DFS) and overall survival (OS) were compared. SPSS 21.0 software was used for all data. DFS and OS were compared and analyzed by Kaplan-Meier and Log-rank test.
Linear regression and automatic linear regression showed lymph node positive functional equations by tumor-node-metastasis staging from AJCC-7 and tumor-node-metastasis staging from AJCC-8. Neurological invasion, venous infiltration, lymphatic infiltration, and tumor deposition put forward stricter requirements for pathological examination in AJCC-8 compared to AJCC-7. After re-analyzing our cohort with AJCC-8, the percentage of stage IVB cases decreased from 2.8% to 0.8%. As a result 2% of the cases were classified under the new IVC staging. DFS and OS was significantly shorter ( = 0.012) in stage IVC patients compared to stage IVB patients.
The addition of stage IVC in AJCC-8 has shown that peritoneal metastasis has a worse prognosis than distant organ metastasis in our institution's CRC cohort. Additional datasets should be analyzed to confirm these findings.
根据美国癌症联合委员会分期系统(AJCC - 7和AJCC - 8)第七版和第八版推荐的不同分类,分析结直肠癌(CRC)的生存趋势。
查询本机构数据库,以确定2006年至2012年间病理确诊为0 - IV期CRC的患者。收集2080例患者的数据,并通过标准化的纳入和排除标准评估1090例患者。CRC按AJCC - 7分期,然后再按AJCC - 8重新分期。比较5年无病生存率(DFS)和总生存率(OS)。所有数据均使用SPSS 21.0软件。通过Kaplan - Meier法和Log - rank检验对DFS和OS进行比较和分析。
线性回归和自动线性回归显示了AJCC - 7的肿瘤 - 淋巴结 - 转移分期和AJCC - 8的肿瘤 - 淋巴结 - 转移分期的淋巴结阳性功能方程。与AJCC - 7相比,AJCC - 8对神经侵犯、静脉浸润、淋巴浸润和肿瘤沉积提出了更严格的病理检查要求。用AJCC - 8重新分析我们的队列后,IVB期病例的百分比从2.8%降至0.8%。结果,2%的病例被归类为新的IVC期。与IVB期患者相比,IVC期患者的DFS和OS显著缩短(P = 0.012)。
AJCC - 8中增加IVC期表明,在本机构的CRC队列中,腹膜转移的预后比远处器官转移更差。应分析更多数据集以证实这些发现。